Matsuzaki et al. found, in an extensive study, that bikunin protein in the plasma of women with ovarian cancer (N = 327), compared to those with benign ovarian mass (N = 200) and healthy controls (N = 200), may be useful in evaluating the prognosis of the disease. The gene discussed is AMBP; the disease is ovarian carcinoma.